Visit KQAK 105.7
Visit The Peak 104.1
Visit 95.7 The Ranch
Visit 92.5 The Ticket
Visit KBNW 104.5AM AND 1340AM
Recent Quotes
My Watchlist
Indicators
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

First Tracks Biotherapeutics, Inc. - Ordinary Shares (NQ:TRAX)

34.05 +2.20 (+6.91%)
Delayed Quote Updated: 4:00 PM EDT, Oct 12, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about First Tracks Biotherapeutics, Inc. - Ordinary Shares

News headline image
First Tracks Biotherapeutics Announces Positive Top-Line Results for ANB033 in Gluten-Challenge Study in Celiac Disease
From First Tracks Biotherapeutics Inc
Via GlobeNewswire
News headline image
First Tracks Biotherapeutics to Announce Top-Line Data from Cohort 1 of Phase 1b Trial of ANB033, a CD122 antagonist, in Celiac Disease on Oct. 12, 2026
From First Tracks Biotherapeutics Inc
Via GlobeNewswire
News headline image
First Tracks Biotherapeutics Announces Participation in September Investor Conferences
From First Tracks Biotherapeutics Inc
Via GlobeNewswire
News headline image
First Tracks Biotherapeutics Announces Second Quarter 2026 Financial Results and Provides Business Update
From First Tracks Biotherapeutics Inc
Via GlobeNewswire
News headline image
First Tracks Biotherapeutics Announces Participation in Upcoming Investor Conferences
From First Tracks Biotherapeutics Inc
Via GlobeNewswire
News headline image
First Tracks Biotherapeutics Announces First Quarter 2026 Financial Results and Provides Business Update
From First Tracks Biotherapeutics Inc
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.